BP005677: Biotinylated Human IL-13 Protein with the N-His-Avi Tag
Source: The recombinant Biotinylated Human IL-13 Protein, (amino acids Gly21-Asn132) fused with a His-Avi tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human IL-13 protein with the N-His-Avi tag at 2 ug/ml (100 ul/Well) on streptavidin (5 ug/ml) precoated plate. Dose response curve for the recombinant Human IL-13Ra2 protein with the N-hFc tag with the EC50 of 0.6 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003450: Human IL-13 Protein with No Tag
Source: The recombinant Human IL-13 Protein, (amino acids Gly21-Asn132) fused with No Tag, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human IL-13, No tag at 2 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human IL-13 Ra 2, hFc tag with the EC50 of 0.91 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004836: Human IL-13 Protein with the N-hFc Tag
Source: The recombinant Human IL-13 Protein, (amino acids Gly21-Asn132) fused with a hFc tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human IL-13Ra1 protein with the N-hFc tag at 2 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Human IL-13 protein with the N-hFc tag with the EC50 of 15.8 ng/ml determined by ELISA (QC Test). The affinity constant of 0.399 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005417: Human IL-13 Protein with the N-His-Avi Tag
Source: The recombinant Human IL-13 Protein, (amino acids Gly21-Asn132) fused with a His-Avi tag at the N-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human IL-13 protein with the N-His-Avi tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human IL-13Ra2 protein with the N-hFc tag with the EC50 of 1.0 ug/ml determined by ELISA (QC Test). The affinity constant of 1 uM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004404: Human PGLYRP1 Protein with the C-hFc Tag
Source: The recombinant Human PGLYRP1 Protein, (amino acids Gln22-Pro196) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human TREM1 protein with the C-hFc tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human PGLYRP1 protein with the C-hFc tag with the EC50 of 0.32 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP000136-C088: Recombinant Mouse IL-13
Source: E. coli-derived.
The ED50 of rmIL13 as determined by dose-dependent stimulation of proliferation of TF-1 human erythroleukemic cells was < 2 ug/ml, corresponding to a Specific Activity of 5.0 x 105 IU/mg.
Purity > 95%, by reducing SDS-PAGE and SEC-HPLC.
Endotoxin: Less than 0.1 ng/ug (1 EU/ug).BP000136-CYT-375: Recombinant Mouse IL-13
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 110 amino acids and having a molecular mass of 12 kDa.
The ED50 range=2-6 ug/ml corresponding to a specific activity of 0.17-0.5 MU/mg, determined by the dose dependent prolifiration of TF-1 cells.
Purity > 95%, by SDS-PAGE.BP000136-CYT-391: Recombinant Rat IL-13
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000136-CYT-446: Recombinant Human IL-13
Source: E. coli-derived.
The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of 1 MIU/mg.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000136-CYT-489: Recombinant Human IL-13, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS--PAGE and RP-HPLC.BP000136-CYT-682: Recombinant Human IL-13 Variant
Source: E. coli-derived.
The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of >1,000,000 units/mg. This analog has also been shown to exhibit increased in vivo activity compared to wild type IL-13.
Purity > 95%, by SDS--PAGE and RP-HPLC.BP004389: Mouse PGLYRP1 Protein with the C-hFc Tag
Source: The recombinant Mouse PGLYRP1 Protein, (amino acids Phe19-Glu182) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.